监管与产业动态· FiercePharma·· 6 days agoPickScore52
FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash - Fierce Pharma
In brief
The FDA has approved an expanded indication for ImmunityBio's Anktiva in bladder cancer, ending earlier regulatory setbacks. The source material contains only the headline; the approval scope, trial data and timeline are not given in the current materials.
Why it matters
Hot story: reported by four sources covering the same event.
Source: 监管与产业动态